CME and CFTC Clash Over On-Chain Perpetual Futures

The CME Group, the largest derivatives exchange operator in the US, is locked in a bitter battle with its regulator, the Commodity Futures Trading Commission, over the introduction of blockchain-based perpetual futures products. The CFTC's decision to allow these products has been met with resistance from the CME, which argues that they are harmful to its traditional futures products and that the regulator is mislabeling them. The dispute centers on the definition of a swap and whether perpetual futures, which allow users to speculate on the price of an asset with leverage and no expiration date, should be regulated as such. The CME claims that the CFTC's sudden embrace of perpetual futures did not consider the ramifications and that the products are not compliant with US law. The regulator, on the other hand, argues that it is trying to provide a framework for the growth of the crypto industry and that the CME is trying to stifle competition. The case is set to have significant implications for the US approach to the rapidly growing arena of perpetual futures, with non-US volume reportedly reaching $60 trillion last year. The CME has filed a lawsuit against the CFTC, challenging its decision to allow the listing of crypto perpetual futures by platforms such as Kalshi and Coinbase. The regulator has declined to comment on the matter, but its chairman, Mike Selig, has stated that the CME's decision to disregard the commission's efforts to undertake a reasoned analysis of the issues at stake is wholly inappropriate. The dispute has sparked a heated debate, with some arguing that the CME is trying to protect its dominance in the derivatives market and others claiming that the regulator is not doing enough to ensure that the products are compliant with US law. The outcome of the case is uncertain, but it is clear that it will have a significant impact on the future of the crypto industry and the regulation of perpetual futures in the US.